Decompensated Hepatitis B Cirrhosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Decompensated Hepatitis B Cirrhosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Decompensated Hepatitis B Cirrhosis trials you may qualify for1. Evaluation the safety of using human umbilical mesenchymal stem cells to treat patients with hepatitis B cirrhosis. 2. Observe the curative effect of patient…
Phase I (Single Administration, Randomized, Double-blind, Dose Escalation)Primary Objective: To evaluate the safety and tolerability of Human Umbilical Cord Mes…
The goal of this observational study is to learn if spleen stiffness and other non-invasive markers can help predict recompensation in people with decompensated…
This study aims to conduct a prospective, multicenter, double-blind, randomized, placebo-controlled trial. The planned sample size is 432 patients, with the rat…
The goal of this compassionate access program is to provide early access to REP 2139-Mg for patients with HBV mono-infection or HBV / HDV co-infection who eithe…